Navigation Links
Biotel Announces Strong Results for the First Quarter Ended September 30, 2007, FDA 510(k) Clearance for the Braemar ER900 Wireless Event Recorder
Date:11/14/2007

MINNEAPOLIS, Nov. 14 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announced strong sales and earnings for its first quarter ended September 30, 2007. The Company had net earnings of $170,000, or $0.06 per diluted share, on revenues of $2,751,000. This compares to a net loss of $11,000, or $0.00 per diluted share, on revenues of $2,424,000 for the first quarter of last year.

Highlights for the first quarter are as follows:

-- 13.5% revenue growth, year over year

-- Gross margin of 45.6%, up from 40.7% a year ago

-- Operating expenses reduced to 36.1% of revenues from 40.8% last year

-- Operating margin of 9.5% versus a loss a year ago

-- Net margin of 6.2% versus a loss a year ago

-- Strong balance sheet with no long-term debt

-- Stockholders' equity of $4,115,000, up 4.6% year over year

"We had a strong first quarter beginning our fiscal year with year over year growth in product and service revenues and improved margins," Biotel President and CEO Steve Springrose said. "Compared to the first quarter of fiscal 2007, we had increased sales of our Braemar cardiac event recorders, Holter devices, liposuction and other medical devices. Revenues from our Agility 24/7cardiac monitoring services for clinical research continued to grow rapidly. Biotel continues to serve as a development partner to medical corporations seeking new devices and clinical research services, in keeping with our long-term strategy."

In the first quarter, Biotel held operating expenses flat from a year ago, even with a 10.3% increase in Research and Development. "We continued to put emphasis on R&D to expand our proprietary technology across our product spectrum," Springrose commented. "Most importantly, we received FDA 510(k) clearance in October to market our Braemar ER900 Wireless Event Recorder. This is a cardiac looping recorder and cellular transmitter, the first in a series of Braemar wireless products tha
'/>"/>

SOURCE Biotel Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Teams of highly respected Alzheimer,s researchers failed to replicate ... of this brain disease when they were published last ... results, presented online Feb. 9, 2012, suggested that the ... buildup of beta amyloid plaques (Aβ) a pathological ... mice. According to the authors of the 2012 report, ...
(Date:5/24/2013)... Angeles, CA (PRWEB) May 24, 2013 ... to present the 3rd Annual EB-5 Investment Summit: Dealmakers ... The Dealmakers Conference will focus on exploring alternative finance ... the latest market, legal and economic information, and updates ... professionals within the EB-5 industry. , "Our goal ...
(Date:5/24/2013)... Mike Stoler believes that there is much to be ... York. That’s why he hosts “Building New York—New ... And that’s why he invited Robert Glazer, Chief Executive ... single specialty practice in the greater New York area, ... and sub-specialists service communities throughout New York and New ...
(Date:5/24/2013)... to the National Institutes of Health, Stevens Johnson Syndrome (SJS) ... the skin and mucous membranes. SJS occurs most commonly ... (i). In the early stages SJS presents flu-like symptoms, ... it affects the mucous membranes such as the eyes, mouth ... eye causes conjunctivitis (pink eye). Inflammation of the mouth ...
(Date:5/24/2013)... York, New York (PRWEB) May 24, 2013 ... 101 Mobility® is a leading nationwide sales, ... solutions for both consumer and commercial applications. The ... vertical platform lifts, vehicle lifts for mobility devices, ... among others. 101 Mobility operates over 30 locations, ...
Breaking Medicine News(10 mins):Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2
... , LOS ANGELES, Aug. 24 The following statement ... Wilentz Goldman & Spitzer, P.A., Reed Smith LLP, and Thompson Hine LLP ... California, for the County of Los Angeles, Central Civil West: , ... For the Purchase of the Hormone Replacement Therapy Drugs Estratest or Estratest ...
... FARMINGTON HILLS, Mich., Aug. 24 Premier Inc. ... contract to provide RFID Asset Tracking and Management Solutions for ... the country, comprised of more than 1,700 hospitals and 49,000 ... purchasing power. , , "We are ...
... , , , ... California had an opportunity to "become senior citizens" on Friday thanks ... SCAN Health Plan. The award-winning program is a workshop that provides ... senior" through a series of hands-on exercises and sensory ...
... EDEN PRAIRIE, Minn., Aug. 24 NovoLogix, ... it has achieved full accreditation with the Healthcare Network ... Commission (EHNAC). EHNAC,s HNAP accreditation recognizes excellence in health ... standards and HIPAA regulations. , , ...
... Diseases (NIAID), a component of the National Institutes of ... to establish a consortium of human immune profiling research ... receive funding up to $100 million over five yearsis ... and to understand how it changes following infection or ...
... popular social networking tool that was at first merely ... and family, is emerging as a potentially valuable means ... alerts, as described in a feature article in the ... Telemedicine and e-Health , a peer-reviewed journal published by ...
Cached Medicine News:Health News:The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc. 2Health News:The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc. 3Health News:The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc. 4Health News:USC Gerontology Students Participate in 'Aging Sensitivity Training' Provided by SCAN Health Plan 2Health News:NovoLogix, Inc. Receives EHNAC Healthcare Network Accreditation 2Health News:NovoLogix, Inc. Receives EHNAC Healthcare Network Accreditation 3Health News:NIAID to fund new human immune profiling research centers 2Health News:Twitter and health care -- can a tweet a day keep the doctor away? 2
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... April 19, 2011 Cumberland Pharmaceuticals Inc. ... focused on hospital acute care and gastroenterology markets, today ... acquire the rights to ifetroban, a new Phase II ... the brand name Hepatoren™ (ifetroban) Injection and is evaluating ...
... 18, 2011 Two lawsuits were filed today on ... have failed.  The cases were filed on behalf of ... DePuy Orthopaedics, Inc., DePuy Inc., DePuy International, Ltd., Johnson ... Johnson & Johnson International, Inc. John David Hart of ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 2Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 3Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 4Recalled DePuy Hip Implant Lawsuits Filed in Fort Worth, Texas 2
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Codman Sofwire Cable ... bony fixation including sublaminar ... maxillo facial surgery, sternotomy ... cables and a complete ...
Specially designed combination of demineralized bone fibers and demineralized bone cubes that are both osteoinductive and osteoconductive. Packs well into bone defects. Eliminates the need to mix can...
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
Medicine Products: